BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
105.66
+0.91 (0.87%)
At close: Oct 24, 2025, 4:00 PM EDT
106.38
+0.72 (0.68%)
After-hours: Oct 24, 2025, 7:32 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $25.4 billion as of October 24, 2025. Its market cap has decreased by -9.06% in one year.
Market Cap
25.40B
Enterprise Value
9.23B
1-Year Change
-9.06%
Ranking
Category
Stock Price
$105.66
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $25.40B, an increase of 748.10%. That is a compound annual growth rate of 42.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 25.40B | -7.02% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |